Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study.
Martina BurlandoAstrid HerzumEmanuele CozzaniAurora ParodiPublished in: Clinical and experimental vaccine research (2023)
This study aimed to evaluate if patients under biologics have a lower risk of psoriasis flares after coronavirus disease 2019 (COVID-19) vaccination than other psoriatic patients. Of 322 recently vaccinated patients admitted for psoriasis at the Dermatological Psoriasis Unit during January and February 2022, 316 (98%) had no psoriasis flares after COVID-19 vaccination (79% under biologic treatment, 21% not biologically treated) and 6 (2%) presented psoriasis flares after COVID-19 vaccination (33.3% under biologic treatment, 66.6% not biologically treated). Overall, psoriasis patients under biologic treatment, developed fewer psoriasis flares after COVID-19 vaccination (33.3%), than patients not under biologic treatment (66.6%) (p=0.0207; Fisher's exact test).
Keyphrases
- coronavirus disease
- end stage renal disease
- newly diagnosed
- sars cov
- rheumatoid arthritis
- ejection fraction
- chronic kidney disease
- prognostic factors
- type diabetes
- cystic fibrosis
- metabolic syndrome
- stem cells
- skeletal muscle
- systemic lupus erythematosus
- patient reported outcomes
- bone marrow
- weight loss
- disease activity